Shiferman Gregory L. sold SAGE
February 24, 2025 · Form 4 insider transaction
Shiferman Gregory L. sold 2,502 shares of SAGE Therapeutics Holdings at $7.49 per share, a transaction worth $18.7K. The trade was recorded as shares withheld for taxes and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Disposed (sell-side)
Shares
2,502
Price
$7.49
Total value
$18.7K
InsiderShiferman Gregory L.
RoleOfficer
SecurityCommon Stock
Transaction codeF: Shares withheld for taxes
Transaction dateFebruary 24, 2025
Filing dateFebruary 25, 2025
Shares owned after30,759
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
On February 24, 2025, the reporting person vested 7,500 shares of time-based restricted stock units (RSUs) granted on August 24, 2023 under the Sage Therapeutics, Inc. 2014 Stock Option and Incentive Plan. This grant vested 100% on February 24, 2025. Represents shares withheld to satisfy tax withholding obligations on the vesting of restricted stock units.